JPRN-UMIN000008841已完成未知
Evaluation of renoprotective and hypotensive effects by combined use of irbesartan and amlodipine besilate in elderly patients with hypertension. - Evaluation of renoprotective and hypotensive effects by combined use of irbesartan and amlodipine besilate in elderly patients with hypertension.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with hypersensitivity for the study drugs. 2)Patients with bilateral renal artery stenosis. 3)Patients with hyperkalemia. 4)Patients with eGFR value of 29 mL/min/1.73m2 or less. 5)Patients who uses of corticosteroid and/or immunosuppressant. 6)Patients who are considered to be inappropriate by the investigators.
研究者
相似试验
进行中（未招募）
1 期
This study aims to investigate the potential beneficial effects on the kidney of a new medication called Dapagliflozin in type 2 diabetic patients.Diabetic NephropathyEUCTR2013-004042-42-GBKing’s College London40
已完成
3 期
A study to assess the renoprotective effects of the SGLT2 inhibitor Dapagliflozin in non-diabetic patients with proteinuria: a randomized double blind 6-week cross-over trialChronic kidney diseaseNL-OMON47662niversitair Medisch Centrum Groningen20
进行中（未招募）
1 期
This study will assess the effects of dapagliflozin (a drug that is used in patients with Type 2 Diabetes) on lowering the level of urine protein in patients with non-diabetic kidney disease.Chronic kidney diseaseEUCTR2017-001090-16-NLniversity Medical Center Groningen53
已完成
不适用
Comparison of hypotensive effect and prevention to progression of diabetic nephrolopathy with Olmesartan and Ca channel blocker in patient of type 2 diabetichypertension with type 2 diabetisJPRN-UMIN000004253Endcrinology and Diabetis,Saitama Medical University150
已完成
不适用
A comparative study of renoprotective effect of tolvaptan as an alternative treatment for increasing loop diuretics in patients with chronic kidney disease complicated with chronic heart failurechronic heart failure, chronic kidney diseaseJPRN-UMIN000036119Kawashima hospital40